Neurology 1507 - Neurology Alert - Jul 01, 2011

Target Audience:

This activity is intended for the neurologist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Matthew Fink, MD
Vice Chairman, Professor of Clinical Neurology
Weill Medical College
Chief of Division of Stroke and Critical Care Neurology
NewYork Presbyterian Hospital

Peer Reviewer
M. Flint Beal, MD
Professor and Chairman,
Department of Neurology and Neuroscience

Assistant Editors
John J. Caronna, MD
Professor of Clinical Neurology
Weill Cornell Medical College

Michael Rubin, MD, FRCP(C)

Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders


Steven Karceski, MD
Director of Clinical Trials
Cornell Comprehensive Epilepsy Center
Weill Cornell Medical College

Melissa J. Nirenberg, MD, PhD
Assistant Professor, Neurology and Neuroscience
Weill Cornell Medical College

Susan Gauthier, DO, MS
Assistant Professor of Neurology and Neuroscience
Weill Cornell Medical College


  • Bacterial Meningitis: Rarer, in Older Patients, but Equally Deadly
  • Variant Creutzfeldt-Jakob Disease: A Review of 150 Cases
  • REM Sleep Behavior Disorder and Biomarkers of Neurodegenerative Disease
  • Common Entrapment Neuropathies and Chronic Inflammatory Demyelinating Neuropathy
  • Are We Close to Understanding the Role of Fingolimod in the Treatment of MS?
  • Stroke Alert: A Review of Current Clinical Stroke Literature


  • Present current scientific data regarding diagnosis and treatment of neurologic disease, including stroke, Alzheimer?s disease, transient ischemic attack, and coma
  • Discuss the pathogenesis and treatment of pain
  • Present basic science lessons in brain function
  • Discuss information regarding new drugs for commonly diagnosed diseases and new uses for traditional drugs
  • Discuss nonclinical issues of importance to neurologists, such as the right to die and the physician?s legal obligation to patients with terminal illness

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, reports no consultant, stockholder, speaker’s bureau, research, or other relationships related to this field of study. Author Joseph E. Safdieh, MD, Susan Gauthier, DO, MS, assistant editors John J. Caronna, MD, Melissa J. Nirenberg, MD, PhD, Michael Rubin, MD, FRCP(C), and peer reviewer M. Flint Beal, MD, report no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company having ties to this field of study.

Copyright 2011 AHC Media LLC. All rights reserved.